- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
If you have watched Shrinking, you likely recall its disarmingly honest tone. The series blends humor, grief, and complex human relationships in a way that ... Read more The post Parkinson’s Disease vs. Shrinking: What the Show Gets Right (and Wrong) About a Complex Condition appeared first on Perspectives from Gain Therapeutics.
According to a study by the BMJ Today, there will be 25.2 million people living with Parkinson’s disease globally. This a direct 112% increase from ... Read more The post What to Do After Being Diagnosed With Parkinson’s: Treatment, Lifestyle and Support appeared first on Perspectives from Gain Therapeutics.
Operator Good afternoon, everyone. I want to welcome you this afternoon to Gain Therapeutics Parkinson’s Disease KOL Event “Biomarkers, Clinical Endpoints, and the Path to ... Read more The post Parkinson’s Disease KOL Event appeared first on Perspectives from Gain Therapeutics.
The neuroscience community converged in San Diego for Neuroscience 2025, the flagship annual meeting of the Society for Neuroscience. Held from November 15–19 at the ... Read more The post Neuroscience 2025: Key Themes, Emerging Trends, and Gain Therapeutics’ Latest Findings appeared first on Perspectives from Gain Therapeutics.
According to a 2025 study published in the British Medical Journal, Parkinson’s disease is the second most common neurodegenerative disease in the world. Living with ... Read more The post 3 Easy Ways to Adapt Your Home for People with Parkinson’s appeared first on Perspectives from Gain Therapeutics.
The International Congress of Parkinson’s Disease and Movement Disorders® (MDS Congress) will convene this year in Honolulu, Hawaii, from October 5–9, 2025. Organized by the ... Read more The post Advancing Global Dialogue in Neurology: A Preview of the MDS Congress 2025 appeared first on Perspectives from Gain Therapeutics.
Parkinson’s Disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease. Currently, around 1.1 million people in the US are affected by PD. Researchers ... Read more The post The Parkinson’s Caregiver: 7 Ways To Help Your Loved One appeared first on Perspectives from Gain Therapeutics.
Participating in a clinical trial is a personal decision, and making that decision will look different for everyone. As a caregiver, you are among the ... Read more The post Is your loved one ready for a clinical trial? appeared first on Perspectives from Gain Therapeutics.
GBA1 Canada (G-Can) stands at the forefront of neurodegenerative disease research, focusing on the GBA1 gene—a critical player in Parkinson’s disease (PD) and Lewy body ... Read more The post Advancing GBA1 Research: A Glimpse into GBA1 Canada’s Mission and Impact appeared first on Perspectives from Gain Therapeutics.
Clinical trials are the engine of medical innovation. Every approved treatment or therapy on the market today began its life in a lab and went ... Read more The post What Trial Enrollment Looks Like: From Preclinical Screenings to Participation appeared first on Perspectives from Gain Therapeutics.